KOSDAQ · Healthcare · ₩2T
₩47,550-2.56%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.2% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“이번 분기 치료제 성과가 수익으로 이어질 기반을 다졌어요.”
In the company's words · 2026 2분기 filing